Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Danaher to Present at Evercore ISI HealthCONx Conference
05:00pm, Tuesday, 26'th Nov 2024
WASHINGTON , Nov. 26, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conf
Revving Up: 2 Underperforming Dividend Giants Ready To Outshine
04:45pm, Thursday, 14'th Nov 2024
Two high-quality dividend stocks are finally positioned for a strong rebound. After a period of underperformance, their growth potential is back in focus. These companies have adapted well to recent c
Danaher (DHR) Reliance on International Sales: What Investors Need to Know
10:15am, Monday, 28'th Oct 2024
Examine Danaher's (DHR) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.
06:15am, Saturday, 26'th Oct 2024
These seven companies are transforming steady profits into rising passive income streams for investors.
Understanding Danaher's Cautiousness
09:04am, Friday, 25'th Oct 2024
Danaher reported okay Q3 earnings, with "cautiousness" probably being the best adjective to describe the release. The company has finally returned to growth and forward-looking commentary seems positi
Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating
03:27pm, Tuesday, 22'nd Oct 2024
On Tuesday, Danaher Corp DHR reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion.
Danaher Q3 Earnings Surpass Estimates, Diagnostics Sales Up Y/Y
02:10pm, Tuesday, 22'nd Oct 2024
DHR's third-quarter earnings and sales surpass estimates, benefiting from the solid performance of its Life Sciences and Diagnostics segments.
Stock Markets Taper on High Valuations, Upcoming Election
11:25am, Tuesday, 22'nd Oct 2024
In two weeks we potentially could see a number of prominent news items which could change the trajectory of stock market enthusiasm.
Danaher Corporation (DHR) Q3 2024 Earnings Call Transcript
11:12am, Tuesday, 22'nd Oct 2024
Danaher Corporation (NYSE:DHR ) Q3 2024 Earnings Call Transcript October 22, 2024 8:00 AM ET Company Participants John Bedford - VP of IR Rainer Blair - President and CEO Matt McGrew - EVP and CFO Con
Danaher (DHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
10:35am, Tuesday, 22'nd Oct 2024
While the top- and bottom-line numbers for Danaher (DHR) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compar
Danaher (DHR) Tops Q3 Earnings and Revenue Estimates
08:11am, Tuesday, 22'nd Oct 2024
Danaher (DHR) came out with quarterly earnings of $1.71 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $2.02 per share a year ago.
Danaher beats quarterly profit estimates on strong demand for bioprocessing unit
07:13am, Tuesday, 22'nd Oct 2024
Danaher on Tuesday beat Wall Street estimates for third-quarter profit on strong demand for its diagnostics and bioprocessing businesses, alongside growth in its molecular testing unit.
Danaher Reports Third Quarter 2024 Results
06:00am, Tuesday, 22'nd Oct 2024
WASHINGTON , Oct. 22, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September 27, 2024. All results in this release reflect onl
Exploring Analyst Estimates for Danaher (DHR) Q3 Earnings, Beyond Revenue and EPS
10:21am, Thursday, 17'th Oct 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Danaher (DHR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Cramer's Mad Dash: Danaher
09:54am, Thursday, 17'th Oct 2024
CNBC's Jim Cramer delivers his daily Mad Dash.
